Publications
-
Growth patterns in the first year of life differ in infants born to perinatally vs.
Citation: Jao J, Agwu A, Mhango G, Kim A, Park K, Posada R, Abrams EJ, Hutton N, Sperling RS. Growth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women. AIDS. 2015 Jan 2;29(1):111-6. doi: 10.1097/QAD.0000000000000501. PMID: 25562495; PMCID: PMC4326225
Date: 01/02/2015
Changes in metabolic syndrome status after initiation of antiretroviral therapy
Citation: Krishnan S, Schouten JT, Atkinson B, Brown TT, Wohl D, McComsey GA, Glesby MJ, Shikuma C, Haubrich R, Jacobson DL. Changes in metabolic syndrome status after initiation of antiretroviral therapy. J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):73-80. PMID: 25321179. PMCID: PMC4262682
Date: 01/01/2015
Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and
Citation: Sacktor N, Miyahara S, Evans S, Schifitto G, Cohen B, Haughey N, Drewes JL, Graham D, Zink MC, Anderson C, Nath A, Pardo CA, McCarthy S, Hosey L, Clifford D; ACTG A5235 team. Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. J Neurovirol. 2014 Dec;20(6):620-6. doi: 10.1007/s13365-014-0292-0. Epub 2014 Nov 7.
Date: 12/15/2014
Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir
Citation: Persaud D, Patel K, Karalius B, Rainwater-Lovett K, Ziemniak C, Ellis A, Chen YH, Richman D, Siberry GK, Van Dyke RB, Burchett S, Seage GR, Kuzuriaga K, Pediatric HIV/AIDS Cohort Study. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents JAMA Pediatr. 2014 Dec;168(12):1138-46. PMID 25286283; PMCID PMC4324476
Date: 12/01/2014
HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in
Citation: Luzuriaga K, Tabak B, Garber M, Chen YH, Ziemniak C, McManus M, Murray D, Strain MC, Richman DD, Chun TW, Cunningham CK, Persaud D. HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis. 2014 Nov 15;210(10):1529-38. PMID 24850788; PMCID: PMC4215073
Date: 11/15/2014
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not vi
Citation: Shivakoti R, Gupte N, Yang WT, Mwelase N, Kanyama C, Tang AM, Pillay S, Samaneka W, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Semba RD, Christian P, Campbell TB, Gupta A; NWCS 319 and PEARLS study team. Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not vi 3, 4 or death but not virologic failure post-antiretroviral therapy. Nutrients. 2014 Nov 13;6(11):5061-78. doi: 10.3390/nu6115061. PMID: 25401501. PMCID: PMC4245580.
Date: 11/13/2014
Raltegravir pharmokinetics in neonates following maternal dosing
Citation: Clarke DF, Acosta EP, Rizk ML, Bryson YJ, Spector SA, Mofenson LM, Handelsman E, Teppler H, Welebob C, Persaud D, Cababasay MP, Wang J, Mirochnick M. IMPAACTP1097 Study Team. Raltegravir pharmokinetics in neonates following maternal dosing. J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):310-5. PMID 25162819; PMCID: PMC4197108
Date: 11/01/2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral
Citation: Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Manish Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med. 2014 Oct 4;161(7):461-71. PMID: 25285539. PMCID: PMC4412467
Date: 10/04/2014
Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term
Citation: Zheng L, Taiwo B, Gandhi RT, Hunt PW, Collier AC, Flexner C, Bosch RJ. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):153-60. doi: 10.1097/QAI.0000000000000286.
Date: 10/01/2014
Challenges to disclosure of HIV status to perinatally infected children: a study of caregiver
Citation: Suryavanshi N, Raval G, Kanade S, Nimkar S, Nadgiri V, Sahu P, Kadam D, Khadse S, Mave V, Gupte N, Gupta A. Challenges to disclosure of HIV status to perinatally infected children: a study of caregiver perspe study of caregiver perspectives in Pune, India. Journal of Pediatric Infectious Diseases, 9(2), 71-84. DOI: 10.3233/JPI-140418.
Date: 09/15/2014
- ‹ First < 19 20 21 22 23 > Last ›